Outsmarting ovarian cancer. A new test seeks its first traces

Ovarian cancer is a significant health concern, ranking fifth among cancers in Polish women. A new blood test shows promise in detecting early signs of the disease, particularly in women with high-grade serous ovarian cancer. Researchers focused on the Tu-Stroma RNA molecule, which indicates the presence of precancerous changes. The test successfully identified STIC changes in 92.3% of cases, outperforming the current CA125 marker. This advancement could aid women with BRCA1 and BRCA2 mutations, potentially guiding preventive surgeries. However, the test is not yet ready for clinical use and requires further validation.